ARCHIVES

NCI Cooperative Group Trials Approved Last Month By CTEP

This article is from The Cancer Letter archive.

Vol. 33 No. 3 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting

April 29, 2011

NCI Cooperative Group Clinical Trials Approved

November 27, 2009

NCI Initiatives: Two RFAs Planned In New Technologies for Molecular Biology

December 6, 1996

Group Chairman Balk At Board’s Recommendations

February 15, 1980

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

National Policy: IOM Seeks Nominations for Cancer Policy Board

November 29, 1996